Platelet-derived MVs from lung cancer patients are also able to induce metastasis and promote tumor cell invasion by delivering miR-223 that targets tumor suppressor gene EPB41L3 (erythrocyte membrane protein band 4.1-like 3) [210]. Here, EPB41L3 is linked to lung carcinoma.